Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Rhabdoid Tumor × Craniospinal Irradiation × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Meningeal Carcinomatosis 1 Medulloblastoma 1 Lung Neoplasms 1 Intracranial Germ Cell Tumors 1 Infratentorial Neoplasms 1 Glioma 1 Ependymoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 10 Etoposide 7 fludarabine 5 etoposide phosphate 5 Granulocyte Colony-Stimulating Factor 5 Stem Cell Transplantation 4 Melphalan 4 Filgrastim 4 Carboplatin 4 fludarabine phosphate 3 Topotecan 3 Thiotepa 3 Sirolimus 3 Radiotherapy 3 Methotrexate 3 Mesna 3 Ifosfamide 3 Busulfan 3 Automobiles 3 selinexor 2 sargramostim 2 Vincristine 2 Nivolumab 2 Ipilimumab 2 Gemcitabine 2 Cisplatin 2 trametinib 1 thymoglobulin 1 tazemetostat 1 talazoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡